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Abstract 
Aims 
Arterial spin labeling magnetic resonance imaging (ASL MRI) measures perfusion without 
administration of contrast agent. Whilst ASL has been validated in animals and healthy 
volunteers, application to chronic kidney disease (CKD) has been limited. We investigated 
the utility of ASL MRI in patients with CKD. 
Methods 
We studied renal perfusion in 24 healthy volunteers (HV) and 17 patients with CKD (age 22–
77 years, 40% male) using ASL MRI at 3.0T. Kidney function was determined using 
estimated glomerular filtration rate (eGFR). T1 relaxation time was measured using MOLLI  
and FAIR True FISP was performed to measure cortical and whole kidney perfusion.  
Results 
T1 was higher in CKD within cortex and whole kidney, and there was association between 
T1 time and eGFR. No association was seen between kidney size and volume and either T1, 
or ASL perfusion. Perfusion was lower in CKD in cortex (136±37 vs 279±69ml/min/100g; 
p<0.001) and whole kidney (146±24 vs. 221±38ml/min/100g; p < 0.001). There was 
significant, negative, association between T1 longitudinal relaxation time and ASL perfusion 
in both the cortex (r = -0.75, p < 0.001) and whole kidney (r = -0.50, p < 0.001). There was 
correlation between eGFR and both cortical (0.73, p <0.01) and whole kidney (r = 0.69, 
p<0.01) perfusion.  
Conclusions 
Significant differences in renal structure and function were demonstrated using ASL MRI. T1 
may be representative of structural changes associated with CKD, however further 
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investigation is required into the pathological correlates of reduced ASL perfusion and 
increased T1 time in CKD. 
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Introduction 
Renal perfusion is an important physiological parameter in health and disease. In normal 
physiology, renal blood flow is an important determinant of oxygen supply and glomerular 
filtration rate [1] whilst in chronic kidney disease (CKD), renal microvascular dysfunction is 
one of a number of common pathological mechanisms involved in the progression of disease, 
irrespective of the initiating insult.  
Despite this crucial role of perfusion in renal physiology and disease, in vivo measurement 
remains a challenge in both clinical and research settings, as established methods are 
associated with a number of inherent drawbacks. Measurement of the clearance of para-
aminohippuric acid (PAH) is time consuming and invasive [2], whilst computed tomography 
(CT) and nuclear medicine techniques carry a radiation burden, with the former requiring 
administration of nephrotoxic iodinated contrast. Dynamic contrast enhanced (DCE) 
magnetic resonance (MR) techniques can be used to measure renal perfusion but the 
administration of gadolinium-based agents is now relatively contraindicated in patients with 
renal impairment, due to an association with nephrogenic systemic fibrosis [3].  
Arterial spin labeling (ASL) magnetic resonance imaging (MRI) is an imaging technique 
allowing non-invasive measurement of renal perfusion using magnetically labelled blood as a 
contrast agent. Protons in blood are labelled by application of a saturation, or inversion, 
radiofrequency pulse, which then alter tissue magnetization upon exchange with blood within 
capillary beds. An unlabelled image is also acquired, and the ASL signal is determined by 
subtraction of the two. ASL MRI has an inherently low signal-to-noise ratio, due to the low 
contribution of inflowing blood to total tissue magnetisation. Nevertheless, ASL MRI has 
been validated in animals against a microsphere technique [4], and in an explanted kidney 
model [5], with close correlation observed between methods. In humans, good reproducibility 
5 
 
 
 
has been confirmed in healthy volunteer studies [6]. For example, in a recent study a 
coefficient of variance of 9.2% and 7.1% for cortical perfusion and whole kidney perfusion 
was demonstrated [7]. A small number of studies have shown reduced perfusion in patients 
with CKD compared to controls [8,9], and in poorly functioning kidney transplants compared 
to transplants with better function [10-12].  
Nevertheless, ASL MRI has not yet entered widespread clinical use, hampered by lack of 
standardization in sequence acquisition protocols, and post processing methods. The utility of 
ASL MRI as a marker for disease severity and progression in CKD, and as a measure of 
response to therapy, is yet to be determined. We therefore investigated the use of ASL MRI 
for the assessment of patients with CKD.  
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Materials and Methods 
Patients with CKD were recruited from the general nephrology clinic at the Glasgow Renal 
and Transplant Unit, whilst healthy volunteers (HV) were recruited via local advertisement. 
Subjects attended on a single occasion, undergoing clinical and biochemical assessment, and 
subsequent MRI. All subjects gave written informed consent and the local ethics committee 
approved the study. The study is registered with a clinical trials database (ISRCTN 
12301736) and was carried out in compliance with the Declaration of Helsinki.  
Biochemical measurements 
Baseline serum biochemistry and haematology measurements and urinary protein and 
creatinine quantification were obtained. Estimated glomerular filtration rate (eGFR) was 
calculated from the measured serum creatinine using the Chronic Kidney Disease 
Epidemiology Collaboration (CKD–EPI) formula [13]. Proteinuria was measured using a 
spot protein to creatinine ratio (PCR) from a random urine sample. 
Magnetic resonance imaging 
MRI was performed on a Siemens Magnetom Verio 3.0 Tesla scanner (Siemens Erlangen, 
Germany), using a 6-channel phased array body coil. A half Fourier acquisition single shot 
turbo spin echo (HASTE) localizer sequence was used to identify the location of the kidneys 
and vessels, using the following parameters: TR = 1400 ms, TE = 93 ms, voxel size = 2.1 x 
1.5 x 5 mm3, refocusing pulse flip angle = 160o, number of slices = 30, turbo factor = 179, 
bandwidth = 781 Hz/pixel. ASL was performed using a ﬂow-sensitive alternating inversion 
recovery (FAIR) perfusion preparation with true fast imaging and steady precession (True-
FISP) acquisition. A single sagittal double oblique slice of both kidneys was obtained, 
positioned at the mid-point of each axis, moved posteriorly to avoid major vessels. Three 
images with alternating selective and non-selective inversions were obtained in a single 
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acquisition during a 12 second breath-hold, and this was repeated five times.  In addition, an 
image with no ASL preparation was acquired to measure equilibrium magnetization.  Fair 
True-FISP parameters were: inversion time 900 ms, repetition time 3.65 ms, echo time 1.83 
ms, flip angle 60o, field of view 380 x 380 mm, in plane resolution 2.0 x 1.5 mm2, matrix size 
256 x 192, and slice thickness 10 mm. T1 was acquired during a separate breath-hold by a 
modified Look-Locker inversion recovery (MOLLI) sequence, with the following 
parameters: TR = 740 ms, TE = 1.1 ms, voxel size = 2.0 x 1.5 x 6 mm3, flip angle = 35o, 
starting inversion time (TI) = 125 ms, TI increment = 80 ms, number of inversions = 3, 
bandwidth = 930 Hz/pixel. T1 was computed pixel wise using a non-linear curve fitting 
algorithm, using the three parameter signal model [14]. Total scan time was approximately 15 
minutes.  
Image analysis 
Renal anatomy was assessed on localizer images using a commercially available multi-
modality post processing workstation (Siemens Syngo, Siemens, Erlangen, Germany). 
Kidney length was measured on coronal images and volume was measured using a voxel 
count method by tracing contours on each slice of a 22 slice transverse oriented image 
volume. T1 time was measured in cortex, medulla, and whole kidney, and corticomedullary 
differentiation (CMD) was calculated as the ratio of cortex to medulla T1 time. Post 
processing was performed using in house software (MATLAB 8.4 R2014b; MathWorks, 
Natick, Massachusetts, U.S.A). An averaged ASL subtraction image was produced from 
registered subtraction images derived from each breath-hold.  This was fitted to the M0 and 
T1 data using the standard ASL kinetic model [15] to produce a perfusion map. Image co-
registration of ASL, M0 and T1 maps was performed using an enhanced correlation 
coefficient maximization algorithm with affine transformations [16]. Pixel wise computation 
of perfusion was performed according to the following formula, where f = perfusion, ʎ = 
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tissue-blood partition coefficient (0.8 mL/g in kidney), M0 = equilibrium magnetisation, ΔM 
= ASL signal, T1 longitudinal relaxation time, TI = inversion time: 
 
Regions of interest (ROIs) were drawn onto the perfusion map to measure cortical and whole 
kidney perfusion. Total single kidney perfusion, was calculated by multiplying the renal 
perfusion normalised per gram of renal tissue, by the renal mass, assuming that the mass of 
1g per 1cm3 of renal tissue. For each individual the total kidney perfusion, analogous to renal 
blood flow was calculated by combining the kidney blood flow of the left and right kidneys. 
A single operator performed image analysis.  
Statistical analysis 
Results are expressed as mean ± standard deviation. T1 time and perfusion were measured in 
cortical and whole kidney ROIs, and ASL measurements are expressed by unit of mass 
(100g) which is typical in the standard kinetic model. Between group differences in T1 time, 
CMD, and perfusion were evaluated using independent samples Student’s t tests. Evaluation 
of correlation between MRI measurements and serum and urine biochemistry parameters was 
performed using Pearson’s correlation coefficient. Throughout, p values < 0.05 were deemed 
significant. Data were analysed using IBM SPSS Statistics version 22.0 (IBM, Armonk, New 
York, U.S.A). 
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Results 
Baseline data 
24 HV and 17 patients with CKD were recruited; the demographic data for each group is 
displayed in table 1. The CKD group was significantly older (p < 0.05), and had higher blood 
pressure (p < 0.05). CKD-EPI eGFR was 39.8 ± 25.2 ml/min/1.73m2 in the CKD group and 
99.6 ± 14.0 ml/min/1.73m2 in the HV group (p < 0.001). 
Renal anatomy 
Renal anatomical data is shown in table 2. Kidney length was significantly shorter in the 
CKD group compared with the HV group (p < 0.05) however renal volume was no different 
between the two. The CKD group had significantly higher T1 longitudinal relaxation time 
both measured in the cortex (p < 0.001) and the whole kidney (p < 0.01) ROI (figure 1). 
Furthermore, CMD was significantly higher in CKD than in HV (p < 0.001). 
Renal perfusion 
Renal perfusion was significantly lower in the CKD group (table 2 and figure 1). In the CKD 
cohort, mean cortical perfusion was 136 ± 37 ml/min/100g in comparison to 279 ± 69 
ml/min/100g in the HV cohort (p < 0.001). Similarly, whole kidney perfusion was reduced in 
the CKD group, at 146 ± 24 ml/min/100g compared to 221 ± 38 ml/min/100g (p < 0.001). 
Furthermore, total renal perfusion was 446 ± 150 ml/min in CKD compared to 731 ± 158 
ml/min in HV (p < 0.001). Typical perfusion maps from both groups are shown in figure 2.  
Intra-observer variability 
Intra-observer variation of cortical perfusion measurements was 7.3% with intra-class 
correlation (ICC) of 0.98, whilst variation of whole kidney perfusion measurements was 
found to be 4.4% with ICC of 0.96. 
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Association between renal anatomical and functional parameters 
There was significant, negative, association between T1 longitudinal relaxation time and ASL 
perfusion measured in both the cortex (r = -0.75, p < 0.001) and whole kidney (r = -0.50, p < 
0.001). No significant association was seen between kidney length or volume and either ASL 
perfusion measurements, or T1 longitudinal relaxation time.   
Correlation of clinical, biochemical and MRI parameters 
Both cortical and whole kidney perfusion were found to have a negative association with age 
(respectively, r = -0.48, p < 0.01; r = -0.51, p < 0.01). Whilst there was no association 
between blood pressure and cortical perfusion, a negative correlation was observed between 
whole kidney perfusion and mean arterial blood pressure (r = -0.33, p < 0.05). 
Correlation was seen between eGFR and both whole kidney T1 longitudinal relaxation time 
(r = -0.40, p < 0.05) and cortical T1 time (r = -0.58, p < 0.001). Furthermore, significant 
correlation was seen between eGFR and both cortical perfusion (r = 0.73, p < 0.01) and 
whole kidney perfusion (r = 0.69, p < 0.01). There was also significant correlation between 
total renal perfusion and eGFR (r = 0.69, p < 0.01). PCR was negatively correlated with both 
cortical (r = -0.60, p < 0.01) and whole kidney perfusion (r = -0.43, p < 0.05) (figure 3).  
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Discussion 
CKD has a tendency to worsen despite treatment of blood pressure and any other reversible 
or aetiological factors, and there is evidence that common pathological mechanisms are 
responsible for this irrespective of the original renal insult. Renal damage has been shown to 
correlate primarily with tubulointerstitial injury [17], characterised by a vicious cycle of 
microvasculature dysfunction leading to tubular atrophy and fibrosis [18]. In vivo biomarkers 
to assess renal progression are lacking and emerging techniques such as ASL MRI may 
provide much needed insight into renal perfusion and thus extent of renal damage.  
We found that cortical perfusion is reduced from 279 ml/min/100g in HV to 136 ml/min/100g 
in patients with CKD, with correlation between perfusion and degree of renal impairment 
quantified by eGFR. Whole kidney perfusion is similarly reduced, from 221 ml/min/100g to 
146 ml/min/100g. This is in keeping with previous measurements of renal perfusion in health 
and disease, and the finding of reduced native kidney perfusion in CKD has also previously 
been demonstrated [9,12]. Whilst our perfusion values are lower than found in other studies, 
this CKD cohort represents the largest to undergo ASL MRI and included patients with more 
advanced renal impairment than previously studied. Our findings demonstrate strong 
correlation of renal function to perfusion across a broad range of CKD-EPI eGFR, ranging 
from 20 to 126 ml/min/1.73m2.  
Earlier human studies using ASL MRI are summarised in table 3, which demonstrates the 
range of perfusion values previously demonstrated. The broad range could be ascribed to 
differences in ASL sequence, imaging strategy, and post processing as well as true 
differences in study population. For example, different strategies have been employed to 
circumvent the problem of renal respiratory motion, including breath-holding, respiratory 
gating, or post processing registration. Gardener & Francis [19] found no difference in 
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perfusion measurements made with either breath-holding or free breathing, but found reduced 
perfusion when background suppression was used to improve image quality, showing that 
some variations in imaging approach cause differences in perfusion measurements. Our ASL 
technique resulted in a scan time of 15 minutes, and breath-holding time of 12 seconds, 
which was tolerated by all participants.  
ASL has been validated in animal models using microsphere techniques and using explanted 
organs undergoing haemoperfusion. In normal renal function, strong correlation between 
ASL and both DCE MRI perfusion [20], and PAH clearance [21] has been shown. Validation 
of ASL against a gold standard perfusion technique has not, to our knowledge, been 
undertaken in a CKD population. Given that quantitative measurement of perfusion using the 
standard ASL kinetic model is dependent on T1 time, it is possible that structural changes in 
CKD are at least partly responsible for the functional changes measured by ASL MRI. In 
keeping with previous studies [22], we have shown that T1 time is significantly higher in 
CKD, and that T1 time shows strong correlation with CKD-EPI eGFR. Lee et al [23] 
previously showed that cortical T1, but not medullary T1 time showed strong correlation with 
single kidney GFR measured by renography. These differences may be accounted for by 
changes in extracellular composition, fibrosis, or in the microvasculature, and further 
investigation is required into the association between the pathological changes in CKD, T1 
time, and ASL perfusion. Notably, there was stronger association between eGFR and whole 
kidney ASL perfusion (r = 0.69, p < 0.01) than T1 time (r = 0.40, p < 0.05) suggesting that 
ASL does grant some additional information into renal physiology in CKD, in addition to the 
structural changes identified by differences in T1 time. Additionally, there was no association 
between ASL and kidney size or volume, suggesting that the difference in perfusion in CKD 
is not entirely attributable to tissue atrophy.  
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ASL MRI is but one of a number of emerging MRI techniques which may have utility in 
CKD, such as blood oxygen level dependent (BOLD) imaging, and diffusion weighted (DWI) 
and diffusion tensor imaging (DTI). Future research should be guided at identifying the 
imaging correlates of renal fibrosis in CKD, as this may allow identification of biomarkers 
which can prognosticate, guide therapy, and act as surrogate markers of renal progression in 
studies of novel therapeutics in CKD.  
Our study has a number of limitations. Our CKD cohort has a variety of renal pathologies and 
whilst common pathological mechanisms underpin all chronic kidney disorders it is possible 
that perfusion abnormalities may predominate in certain aetiologies of CKD over others. 
Despite attempts to match the two groups, mean age was higher in the CKD than HV cohort, 
and therefore the changes in ASL MRI may not be independent of aging. Despite being one 
of the largest ASL studies in CKD, even larger studies are required to confirm our findings 
and exclude the possibility of group effects confounding some of the associations with the 
biochemical parameters which were measured. Furthermore, we have used the standard ASL 
kinetic model which is primarily validated in healthy volunteers and assumes constant arterial 
transit time and blood tissue exchange. Differences in these factors may artefactually alter 
perfusion measurements in CKD, and as previously discussed further research is necessary to 
validate the use of ASL in the CKD population. Lastly, our study was carried out using 3.0T 
MRI, which is in general less available in clinical use and further work will be required to 
translate our findings to 1.5T platform, as it is more commonly used in clinical practice.  
In conclusion, we have shown significant differences in renal perfusion measured with ASL 
MRI in a group of patients with advanced CKD, and shown correlation to renal parameters 
such as eGFR.  
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Legends to Figures 
Figure 1 
Box and whisker plot of T1 longitudinal relaxation time and perfusion in healthy volunteers 
and CKD. 
Figure 2 
ASL MRI perfusion maps from a healthy volunteer (A) and patient with chronic kidney 
disease stage 3/4 (B) with an eGFR of 30 ml/min/1.73m2. Both whole kidney (1 & 2) and 
cortical (3 & 4) perfusion are demonstrated. Cortical thinning, reduced corticomedullary 
differentiation, and reduced global perfusion can be seen in CKD. 
Figure 3 
Association between biochemical measurements and ASL. Correlation was observed between 
eGFR and cortical perfusion (r = 0.73, p < 0.01) (A), and eGFR and whole kidney perfusion 
(r = 0.69, p < 0.01) (B).  
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Tables 
 
Table 1. Baseline parameters. Baseline clinical and biochemical parameters are shown of 
healthy volunteers and patients with chronic kidney disease. Results are shown as mean ± 
standard deviation.  
Parameter Healthy 
volunteers 
Chronic kidney 
disease 
p value 
Number 24 17  
Age (years) 47 ± 14 56 ± 10 < 0.05 
Body mass index (kg/m2) 26.5 ± 5.3 29.3 ± 3.4 0.06 
Blood pressure (mmHg) 132/83 ± 15/8 151/90 ± 26/14 < 0.05 
Mean arterial blood pressure 
(mmHg) 
99 ± 9 110 ± 17 < 0.05 
CKD-EPI eGFR (ml/min/1.73m2) 99.6 ± 14.0 39.9 ± 25.2 < 0.001 
Serum creatinine (µmol/L) 68 ± 10 184 ± 69 <0.001 
Primary renal diagnosis (number)    
 Diabetes  2  
 Glomerulonephritis  8  
 Renovascular disease  4  
 Other   2  
 CKD-cause unknown  1  
CKD stage (number)    
1 
2 
3 
4 
5 
 2 
1 
4 
10 
0 
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Table 2. MRI parameters. Measurements of renal anatomy, T1 longitudinal relaxation 
time, and ASL MRI perfusion are shown in healthy volunteers and chronic kidney disease. 
Results are shown as mean ± standard deviation.  
Parameter Healthy 
volunteers 
Chronic kidney 
disease 
p value 
Kidney length (cm) 10.5 ± 0.8 9.7 ± 0.9 < 0.05 
Kidney volume (cm3) 167.1 ± 35.0 160.1 ± 53.4 0.62 
Cortical T1 time (ms) 1366 ± 122 1529 ± 77 < 0.001 
Whole kidney T1 time (ms) 1472 ± 91 1550 ± 81 < 0.01 
Corticomedullary differentiation 0.84 ± 0.07 0.94 ± 0.07 < 0.001 
Mean cortical perfusion 
(ml/min/100g) 
279 ± 69 136 ± 37 < 0.001 
Mean whole kidney perfusion 
(ml/min/100g) 
221 ± 38 146 ± 24 < 0.001 
Mean kidney perfusion (ml/min) 366 ± 79 223 ± 75 < 0.001 
Total renal perfusion (ml/min) 731 ± 159 446 ± 150 < 0.001 
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Table 3. Human studies in arterial spin labeling, grouped by cohort (kidney disease, hypertension, and healthy volunteers). Perfusion 
measurements are displayed as mean ± standard deviation unless otherwise stated. TI = inversion time, FAIR = flow sensitive inversion 
recovery, GRASE = gradient and spin echo, FISP = fast imaging with steady state precession, SSFSE = single shot fast spin echo, SSFP = single 
shot free precession, spin-echo echo planar imaging, BS = background suppression, HASTE = half Fourier acquisition single shot turbo spin 
echo, UFLARE =  ultra-fast low angle rare, T = Tesla, HF = heart failure, HV = healthy volunteer, HTN = hypertensive, CKD = chronic kidney 
disease, RAS = renal artery stenosis, eGFR = estimated glomerular filtration rate. 
Author Journal Year ASL 
 
Field 
strength 
Population & number Perfusion (ml/min/100g) 
Whole kidney Cortex Medulla 
Breidthardt 
et al [24] 
Eur. Radiol. 2015 FAIR 1.5T HF eGFR < 60 ml/min/100g (n=10) 
HF eGFR > 60 ml/min/100g (n=10) 
Age matched HV (n=10) 
HV < 40 years (n=10) 
 
 146 ± 50 
171 ± 31 
274 ± 65 
278 ± 59 
 
Heusch et al 
[11] 
J. Magn. 
Reson. Im. 
2013 FAIR True FISP  
 
 
 
 
1.5T & 3T Kidney transplant 
eGFR > 30 
eGFR < 30 
 
282.7 ± 60.8 
178.2 ±63.3 
  
Rossi et al 
[9] 
 
 
 
Invest. 
Radiol. 
2012 FAIR True FISP 3T HV (n=8) 
CKD (mean eGFR 69 ± 12 ml/min 
by inulin clearance) (n=9) 
 
301 ±  51 
 
244 ± 77 
329 ± 52 
 
263 ± 81 
 
Artz  et al 
[12] 
Magn. 
Reson. 
Imaging. 
2011 FAIR b-SSFP 1.5T HV (n=5) 
CKD (n=5) 
Kidney transplant with  
eGFR > 60 ml/min/1.73m2 (n=5) 
Kidney transplant with eGFR < 60 
ml/min/1.73m2 (n=10) 
 
 
 
 
 
 
 
 
 
 
427 ± 20 
225 ± 85 
314 ± 41 
 
235 ± 91 
85 ± 33 
60 ± 23 
37 ± 21 
 
36 ± 14 
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Lanzman et 
al [10]  
Eur. Radiol. 2010 FAIR True FISP 1.5T  Kidney transplant with stable 
function (n=6) 
Recent kidney transplant (n=7) 
Acute transplant dysfunction (n=7) 
 
 
 
 
 
 
 
304.8 ± 34.4 
 
296.5 ± 44.1 
181.9 ± 53.4 
 
Fenchel et 
al [25] 
Radiology 2006 FAIR True FISP  1.5T Patients with RAS (n=12) 
 
 
 
 
HTN but no RAS (n=6) 
 
 
Asymmetry of perfusion values 
Significant differences between perfusion 
in kidney with high grade compared to no 
or low grade RAS 
 
243 ± 59 
 
 
 
 
 
323 ± 79 
 
 
 
 
 
113 ± 22 
 
Michaely et 
al [8] 
Invest. 
Radiol. 
2004 FAIR HASTE 1.5T CKD (renovascular or other 
aetiology) (n=46) 
Not quantified but reduced ASL signal on 
semi- quantitative analysis  
 
  
Ott et al [26] CJASN 2013 FAIR True FISP 1.5T HTN, before and after renal 
denervation (n=19) 
 
 
256.8 (IQR 241 – 278)   
Schneider et 
al [27] 
CJASN 2012 FAIR True FISP 1.5T HTN, before and after 4 weeks of 
oral  aliskiren therapy (n=34) 
 
 
272 ±25   
Ritt et al[21] NDT 2010 FAIR True FISP 1.5T Males with metabolic syndrome 
before and after 2 weeks of oral 
telmisartan therapy (n=24) 
 
253 ±20   
 
Cutajar et al 
 
Eur. Radiol. 
 
2014 
 
Multi TI FAIR 3D 
 
1.5 T 
 
HV (n=16) 
 
 
 
263± 41 
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[20] GRASE 
 
 
 
Gillis et al [7] BMC 
Nephrol. 
2014 FAIR True FISP 
 
 
3 T HV (n=12) 229 ± 41 327 ± 63  
Park et al 
[28] 
Magn. 
Reson. 
Imaging. 
 
2013 Pseudocontinuo
us ASL 
3T HV (n=1)  320 
 
 
Wang et al 
[29] 
Acad. 
Radiol. 
2012 FAIR SSFSE 3T HV, before and after intravenous 
furosemide (n=11) 
 
 366.6 ± 41.2 
 
 
 
118.59 
 
 
Cutajar et al 
[6]  
MAGMA 2012 Multi TI FAIR 3D 
GRASE 
1.5T HV (n=20) 147 ± 30.8 178 ± 40.7  
 
 
 
Gardener 
AG & 
Francis ST 
[19] 
Magn. 
Reson. 
Imaging. 
2010 FAIR True FISP 
 
SE-EPI with & 
without BS 
1.5T HV (n=9) 
FAIR TRUE FISP 
SE-EPI with BS 
SE EPI without BS 
 
 
 
 
 
 
 
367 ± 50 
284 ± 75 
334 ± 65 
 
103 ± 27 
139 ± 55 
122 ± 48 
Kiefer et al 
[30] 
Acad. 
Radiol. 
 
2009 FAIR TrueFISP 3T HV (n=11)  245 ± 11 109 ± 5 
Karger et al 
[31] 
Magn. 
Reson. 
Imaging. 
2000 FAIR UFLARE 1.5T HV (n=10) 213 ± 55   
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Figure 1 
24 
 
 
 
 
Figure 2 
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Figure 3 
